// App-Quantinova.ai

3161 : Antisense therapy for Fuchs endothelial corneal dystrophy ameliorates TCF4 repeat‐expansion mediated toxicity

Researchers

Presenter

  • A. Davidson

Principal Investigators

  • N/A

Medical Centers

  • UCL, Institute of Ophthalmology, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Ophthalmology (OP)

  • Genetic Disorder

Disease

  • Fuchs corneal dystrophy

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved